Energy & climate · Pipeline & development
New Treatment Strategy for Down Syndrome Shows Promise in Phase 2 Clinical Trial
Phase 2 clinical trial published in Cell Reports Medicine finds JAK inhibitor safely reduces immune overactivity, improves inflammatory skin conditions and opens new avenues for research on brain health and Alzheimer's disease The takeaway: Researchers at the Linda Crnic Institute for...
Original source
Read the source — prnewswire.com ↗We link to the original publisher. The summary above is a short guide; read the original for the full details.